CClinicalTrials.gg
Status unknownNCT04422782PrediDengueUpdated Dec 10, 2020

New Tools for Predicting Capillary Leak Shock During Dengue Fever

An interventional study of For each routine sample, an additional tube will be collected to measure the osmotic pressure in the blood and urine in Dengue Fever, Children and Adults, sponsored by Centre Hospitalier de Cayenne. Status unknown at 1 site in France. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2020-12-10.

Sponsored by Centre Hospitalier de Cayenne · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Dec 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
342
Allocation
Not applicable
Ages
5 Years and older
Sex
All
01

Study summary

Evaluate the prognostic value of different methods (Osmometry / clinical-biological score) compared to the occurrence of capillary leak shock during dengue fever.

Read the detailed description

On the South American continent, dengue fever progressively progresses to hyperendemia with co-circulation of different serotypes. Among the complications of dengue fever, a frequent complication is the shock linked to capillary leakage which often occurs at the time of defervescence between the 3rd or 5th day of evolution of the fever. Before that, it is difficult to identify patients who are at risk for severe forms. Patients are therefore seen regularly to monitor for the development of serious forms, which causes saturation of the health system. Despite everything, with each epidemic, the investigators observe deaths of previously healthy people, which always constitutes an important trauma for the population and for the carers. Improving the understanding of the pathophysiology of capillary leakage and the tools to predict it would be significant advances in this common tropical pathology. Thus a retrospective study of longitudinal data during the dengue 2 epidemic of 2013 made it possible to generate precise hypotheses as to the pathophysiology of the shock linked to capillary leakage. Hypoprotidemia and hyponatremia having a strong statistical association with the subsequent occurrence of shock, the hypothesis is of a progressive disturbance of the plasma osmolarity resulting in water leaks towards the interstitial sector.

These preliminary data also made it possible to develop a predictive score which must now be validated over time.

Research involving the human person, monocentric, prospective, validation

Interventional research protocol involving the human person category 2 at risk and minimal constraints

02

Conditions studied

  • Dengue Fever
  • Children
  • Adults

Browse trials for

Keywords

  • Dengue
  • Dengue fever
  • Children
  • Adults
  • French Guiana
  • Hypovolemic shock
  • Osmolarity
  • Hyponatremia
  • Hypoprotidemia
  • Clinical-biological score
  • Interstitial fluid
03

In context

Dengue

279 studies on the registry are indexed under Dengue; 45 are open to participants now.

This study's planned enrollment of 342 is above the median of 123 across 195 interventional studies indexed under Dengue.

Browse Dengue studies →

Lead sponsor

Centre Hospitalier de Cayenne is the lead sponsor of 47 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age> = 5 years
  • Patient / parent consent
  • Exclude other pathology with capillary circulation problem (septic shock, anaphylaxis) All suspected dengue fever requiring hospitalization will be included, final inclusion being after biological confirmation (AgNS1, RT-PCR, serology).

Exclusion criteria

Exclusion Criteria:

  • Age \<5 years
  • Refusal to participate
  • Unsigned consent
  • Coinfection by another agent
  • Patient under guardianship or curatorship.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
342 participants (estimated)

Study arms

  • Other
    Single Arm

    Single Arm

    Other: For each routine sample, an additional tube will be collected to measure the osmotic pressure in the blood and urine

Interventions

  • OtherFor each routine sample, an additional tube will be collected to measure the osmotic pressure in the blood and urine

    Interventional research protocol involving the human person category 2 at risk and minimal constraints

    Also known as: Collection of biological samples : Aliquot of remnants of urine and blood for possible ancillary studies on prognostic factors for occurrence of shock due to capillary leakage during dengue, Systematic search for effusion done in a standardized manner with 3 ultrasound incidences: longitudinal medio axillary, longitudinal medio clavicular and transverse views of the right upper quadrant

06

What researchers measure

Primary outcomes

  1. Occurrence of a shock

    The primary outcome measure will be the occurrence of a shock defined by systolic blood pressure \<90 mm Hg in adults and \<80 mm Hg in children.

    Time frame: 2 years

Secondary outcomes

  1. Predictive value of plasma hypo-osmolarity

    Evaluate the predictive value of plasma hypo-osmolarity in the occurrence of shock during dengue

    Time frame: 2 years

  2. Validation of the clinical-biological prognostic score

    Prospectively validate the clinical-biological prognostic score (2013 shock score) and, if possible, improve it

    Time frame: 2 years

  3. Relationship between the measurements obtained by osmolarity and capillary leakage

    Study the relationship between the measurements obtained by osmolarity and capillary leakage measured by pleural effusion

    Time frame: 2 years

  4. Evaluation of the sensitivity / specificity and predictive values of osmolarity and capillary leakage

    Evaluation of the sensitivity / specificity and predictive values of these measures in relation to the ultrasound objectification of a pleural effusion

    Time frame: 2 years

  5. How long before the shock these measures (osmolarity, score) allow to predict an unfavorable evolution

    Specify how long before the shock these measures (osmolarity, score) allow to predict an unfavorable evolution

    Time frame: 2 years

  6. Association between the factor "Presence of sickle cell disease" and "occurrence of severe dengue"

    Study the association between the factor "Presence of sickle cell disease" and "occurrence of severe dengue"

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
  • General Hospital of Cayenne
    Cayenne, French Guiana 97306, France
    Recruiting
08

References and documents

Publications

  • Djossou F, Vesin G, Elenga N, Demar M, Epelboin L, Walter G, Abboud P, Le-Guen T, Rousset D, Moreau B, Mahamat A, Malvy D, Nacher M. A predictive score for hypotension in patients with confirmed dengue fever in Cayenne Hospital, French Guiana. Trans R Soc Trop Med Hyg. 2016 Dec 1;110(12):705-713. doi: 10.1093/trstmh/trx004. PubMed 28938048 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04422782
Lead sponsor
Centre Hospitalier de Cayenne
Collaborators
European Regional Development Fund
Responsible party
Sponsor
First posted
Jun 9, 2020
Start date
May 14, 2020
Primary completion
May 14, 2022 (estimated)
Completion
May 14, 2023 (estimated)
Last update
Dec 10, 2020

Study contacts

Felix DJOSSOU, MD
Contact
felix.djossou@ch-cayenne.fr
0594395040 ext. +594
DRISP General Hospital of Cayenne
Contact
cicec@ch-cayenne.fr
0594395385 ext. +594
Mathieu NACHER, MD, PhD
study director · Centre Hospitalier de Cayenne

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion